Jump to content

Raffaele De Caterina

Add links
From Wikipedia, the free encyclopedia
(Redirected from Draft:Raffaele De Caterina)

Raffaele De Caterina serves as a Cardiology Professor at the University of Pisa in Italy. Additionally, he holds the position of Director in the Cardiology Division at Pisa University Hospital.[1] De Caterina has authored 750 articles that have undergone peer review and are cataloged in PubMed.[2]

Education

[edit]

Raffaele De Caterina obtained his medical degree from the University of Pisa, Italy, and proceeded to further his education there, gaining postgraduate qualifications in Pulmonary Medicine, Cardiology, Hematology, and Nuclear Medicine. In 1981, he was also awarded a PhD in Cardiovascular Medicine from the Scuola Superiore Sant’Anna in Pisa.[3]

Research & career

[edit]

Thrombosis, atherosclerosis, cardiovascular pharmacology, atrial fibrillation, and the pathogenesis of coronary artery disease are among the key scientific interests of Raffaele De Caterina. He has conducted research on antiplatelet agents and anticoagulants, in their use in cardiovascular therapy.[4][5]

With more than 40 years of professional experience, Raffaele De Caterina is Professor of Cardiology at the University of Pisa, Italy. Prior to obtaining his current role, he was a Lecturer on Medicine at the Brigham and Women's Hospital, Harvard Medical School.[6][7]

Honors

[edit]

Raffaele De Caterina is a Fellow of the European Society of Cardiology, the Italian Society of Cardiology and the Italian Association of Hospital Cardiologists (ANMCO).[8]

Selected publications

[edit]
  • Gentile F, Castiglione V, De Caterina R. Coronary Artery Anomalies. Circulation. 2021;144:983–996.[9]
  • De Caterina R, Ageno W, Agnelli G, et al.: The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations. Thromb Haemost 2019; 119: 14-38.[10]
  • De Caterina R, Husted S, Wallentin L, et al.: Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2016; 115: 685-711.[11]
  • De Caterina R, Husted S, Wallentin L, et al.: General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2013; 109: 569-79.[12]
  • De Caterina R, Husted S, Wallentin L, et al.: Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2013; 110: 1087-107.[13]
  • De Caterina R: n–3 Fatty Acids in Cardiovascular Disease. N Engl J Med 2011; 364:2439-2450.[14]

References

[edit]
  1. ^ "Raffaele De Caterina | Radcliffe Cardiology". www.radcliffecardiology.com. Retrieved 2023-07-09.
  2. ^ "Professor Raffaele De Caterina". esc365.escardio.org. Retrieved 2023-07-09.
  3. ^ Petricciuolo, Serena; Delle Donne, Maria Grazia; Aimo, Alberto; Chella, Antonio; De Caterina, Raffaele (April 2021). "Pre-treatment high-sensitivity troponin T for the short-term prediction of cardiac outcomes in patients on immune checkpoint inhibitors". European Journal of Clinical Investigation. 51 (4): e13400. doi:10.1111/eci.13400. hdl:11382/540882. ISSN 1365-2362. PMID 32894777. S2CID 221541199.
  4. ^ Brüggenjürgen, B.; Schliephacke, T.; Darius, H.; De Caterina, R.; Le Heuzey, J.Y.; Pittrow, D.; Reimitz, P.E.; Schilling, R.J.; Zamorano, J.L.; Kirchhof, P. (November 2014). "Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry". Value in Health. 17 (7): A473. doi:10.1016/j.jval.2014.08.1346. PMID 27201363.
  5. ^ Caselli, C; Ragusa, R; Del Turco, S; De Graaf, M; Basta, G; Scholte, A; De Caterina, R; Neglia, D (2019-10-01). "P6168Low PCSK9 plasma level is an independent predictor of coronary atherosclerotic burden in patients with stable coronary artery disease". European Heart Journal. 40 (Supplement_1). doi:10.1093/eurheartj/ehz746.0774. ISSN 0195-668X. Retrieved 2023-07-09.
  6. ^ "Raffaele De Caterina | Radcliffe Vascular". www.radcliffevascular.com. Retrieved 2023-07-09.
  7. ^ "Home | NEJM Resident 360". mms.org. Retrieved 2023-07-09.
  8. ^ "monasterio.it" (PDF).
  9. ^ Gentile, Francesco; Castiglione, Vincenzo; De Caterina, Raffaele (2021-09-21). "Coronary Artery Anomalies". Circulation. 144 (12): 983–996. doi:10.1161/CIRCULATIONAHA.121.055347. ISSN 0009-7322. PMID 34543069.
  10. ^ Caterina, Raffaele De; Ageno, Walter; Agnelli, Giancarlo; Chan, Noel C.; Diener, Hans-Christoph; Hylek, Elaine; Raskob, Gary E.; Siegal, Deborah M.; Verheugt, Freek W. A.; Lip, Gregory Y. H.; Weitz, Jeffrey I. (January 2019). "The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations". Thrombosis and Haemostasis. 119 (1): 014–038. doi:10.1055/s-0038-1675816. ISSN 0340-6245. PMID 30597497.
  11. ^ Caterina, Raffaele De; Husted, Steen; Wallentin, Lars; Andreotti, Felicita; Arnesen, Harald; Bachmann, Fedor; Baigent, Colin; Collet, Jean-Philippe; Halvorsen, Sigrun; Huber, Kurt; Jespersen, Jørgen; Kristensen, Steen Dalby; Lip, Gregory Y. H.; Morais, João; Rasmussen, Lars Hvilsted (2016). "Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease". Thrombosis and Haemostasis. 115 (4): 685–711. doi:10.1160/TH15-09-0703. ISSN 0340-6245. PMID 26952877.
  12. ^ Caterina, Raffaele De; Husted, Steen; Wallentin, Lars; Andreotti, Felicita; Arnesen, Harald; Bachmann, Fedor; Baigent, Colin; Huber, Kurt; Jespersen, Jørgen; Kristensen, Steen Dalby; Lip, Gregory Y. H.; Morais, João; Rasmussen, Lars Hvilsted; Siegbahn, Agneta; Verheugt, Freek W. A. (2013). "General mechanisms of coagulation and targets of anticoagulants (Section I)". Thrombosis and Haemostasis. 109 (4): 569–579. doi:10.1160/TH12-10-0772. ISSN 0340-6245. PMID 23447024. S2CID 104205.
  13. ^ Caterina, Raffaele De; Husted, Steen; Wallentin, Lars; Andreotti, Felicita; Arnesen, Harald; Bachmann, Fedor; Baigent, Colin; Huber, Kurt; Jespersen, Jørgen; Kristensen, Steen Dalby; Lip, Gregory Y. H.; Morais, Joaõ; Rasmussen, Lars Hvilsted; Siegbahn, Agneta; Verheugt, Freek W. A. (2013). "Vitamin K antagonists in heart disease: Current status and perspectives (Section III)". Thrombosis and Haemostasis. 110 (12): 1087–1107. doi:10.1160/TH13-06-0443. ISSN 0340-6245. PMID 24226379. S2CID 25240330.
  14. ^ De Caterina, Raffaele (2011-06-23). "n–3 Fatty Acids in Cardiovascular Disease". New England Journal of Medicine. 364 (25): 2439–2450. doi:10.1056/NEJMra1008153. ISSN 0028-4793. PMID 21696310.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Raffaele_De_Caterina&oldid=1241738288"